Search research articles
Contact Us
Filters
Showing results (1201-1210 of 1,249) with videos related to
Page
of 125
Sort By:
Blood
|
September 25, 2025
Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia
Tina Bagratuni, Ourania Theologi, Christos Vlachos, et al.
Trials
|
July 26, 2022
The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce-randomised controlled trial
M Poppe, L Duffy, N L Marchant, et al.
Tropical Medicine & International Health : TM & IH
|
May 10, 2014
Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression
Jennyfer Wolf, Annette Prüss-Ustün, Oliver Cumming, et al.
Tropical Medicine & International Health : TM & IH
|
May 1, 2014
Burden of disease from inadequate water, sanitation and hygiene in low- and middle-income settings: a retrospective analysis of data from 145 countries
Annette Prüss-Ustün, Jamie Bartram, Thomas Clasen, et al.
American Journal of Hematology
|
December 24, 2019
Deepening of response after completing rituximab-containing therapy in patients with Waldenstrom macroglobulinemia
Jorge J Castillo, Joshua N Gustine, Andrew Keezer, et al.
Experimental Physiology
|
October 13, 2016
Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons
Jie Zhang, Alan R Light, Charles L Hoppel, et al.
British Journal of Haematology
|
September 19, 2024
ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells
M Munshi, X Liu, A Kofides, et al.
Blood Advances
|
November 8, 2019
Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells
Tomasz Sewastianik, Maria Luisa Guerrera, Keith Adler, et al.
American Journal of Hematology
|
March 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia
Jorge J Castillo, Andrew R Branagan, Alberto Guijosa, et al.
Journal of Translational Medicine
|
January 23, 2019
Climate, human behaviour or environment: individual-based modelling of Campylobacter seasonality and strategies to reduce disease burden
Stephen P Rushton, Roy A Sanderson, Peter J Diggle, et al.
Page
of 125
Search research articles
Search
Showing results (1201-1210 of 1,249) with videos related to
Sort By:
Page
of 125
Blood
|
September 25, 2025
Genomic landscape of IgM-MGUS and patients with stable or progressive asymptomatic Waldenström macroglobulinemia
Tina Bagratuni, Ourania Theologi, Christos Vlachos, et al.
Trials
|
July 26, 2022
The APPLE Tree programme: Active Prevention in People at risk of dementia through Lifestyle, bEhaviour change and Technology to build REsiliEnce-randomised controlled trial
M Poppe, L Duffy, N L Marchant, et al.
Tropical Medicine & International Health : TM & IH
|
May 10, 2014
Assessing the impact of drinking water and sanitation on diarrhoeal disease in low- and middle-income settings: systematic review and meta-regression
Jennyfer Wolf, Annette Prüss-Ustün, Oliver Cumming, et al.
Tropical Medicine & International Health : TM & IH
|
May 1, 2014
Burden of disease from inadequate water, sanitation and hygiene in low- and middle-income settings: a retrospective analysis of data from 145 countries
Annette Prüss-Ustün, Jamie Bartram, Thomas Clasen, et al.
American Journal of Hematology
|
December 24, 2019
Deepening of response after completing rituximab-containing therapy in patients with Waldenstrom macroglobulinemia
Jorge J Castillo, Joshua N Gustine, Andrew Keezer, et al.
Experimental Physiology
|
October 13, 2016
Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons
Jie Zhang, Alan R Light, Charles L Hoppel, et al.
British Journal of Haematology
|
September 19, 2024
ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells
M Munshi, X Liu, A Kofides, et al.
Blood Advances
|
November 8, 2019
Human MYD88L265P is insufficient by itself to drive neoplastic transformation in mature mouse B cells
Tomasz Sewastianik, Maria Luisa Guerrera, Keith Adler, et al.
American Journal of Hematology
|
March 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia
Jorge J Castillo, Andrew R Branagan, Alberto Guijosa, et al.
Journal of Translational Medicine
|
January 23, 2019
Climate, human behaviour or environment: individual-based modelling of Campylobacter seasonality and strategies to reduce disease burden
Stephen P Rushton, Roy A Sanderson, Peter J Diggle, et al.
Page
of 125